Nevertheless, USP9X exhibits tissue-specific expression primarily in brain and the immune system37, and occasionally acts as a tumor suppressor, e.g., in oncogenic KRAS-initiated pancreatic carcinoma38, suggesting the possible existence of additional DUBs that regulate MCL1 stability. This evidence concerns the gene USP9X and neoplasm.